Showing results (91-100 of 196) with videos related to
Sort By:
Pageof 20
Frontiers in Oncology|September 5, 2024
The impact of donor-specific antibodies' presence on the outcome post-allogeneic hematopoietic stem cell transplantation: a survey from a single centerSimona Sica, Elisabetta Metafuni, Filippo Frioni, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 1, 2025
An Analysis of Cytomegalovirus-Specific Cell-Mediated Immunity in a Phase 3, Randomized, Placebo-Controlled Trial of Letermovir Prophylaxis in Cytomegalovirus-Seropositive Recipients of an Allogeneic Hematopoietic Cell TransplantGenovefa A Papanicolaou, Sanjeet S Dadwal, Ella J Ariza-Heredia, et al.Blood|September 28, 2002
Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemiaMaria Teresa Voso, Francesco D'Alo', Rossana Putzulu, et al.Bone Marrow Transplantation|August 22, 2019
Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patientsAndrea Bacigalupo, Anna Maria Raiola, Alida Dominietto, et al.Cytometry. Part B, Clinical Cytometry|December 9, 2017
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemiaFrancesco Corrente, Silvia Bellesi, Elisabetta Metafuni, et al.Cancer Chemotherapy and Pharmacology|October 11, 2011
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescuePatrizia Chiusolo, Sabrina Giammarco, Silvia Bellesi, et al.Frontiers in Immunology|May 21, 2021
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021Andrea Bacigalupo, Idanna Innocenti, Elena Rossi, et al.British Journal of Haematology|November 14, 2024
Predicting therapy-related myeloid neoplasms after CAR-T with the Clonal Haematopoiesis Risk Score (CHRS)Eugenio Galli, Monica Rossi, Ilaria Pansini, et al.Journal of Hematology & Oncology|February 14, 2023
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.Cancers|June 19, 2024
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological RemissionAnna Candoni, Patrizia Chiusolo, Davide Lazzarotto, et al.Pageof 20